
Asthma and COPD Drugs Market to Grow at a CAGR of 7.9% and will Reach USD 73.98 billion by 2032
The prevalence of asthma and COPD are the major factors contributing to market growth. According to a report published by the Asthma and Allergy Foundation US, NY, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- The Asthma and COPD Drugs …